Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Buy
81,295
+2,611
+3% +$306K 0.1% 68
2026
Q1
$9.46M Buy
78,684
+1,326
+2% +$153K 0.09% 66
2025
Q4
$8.14M Buy
77,358
+416
+0.5% +$39K 0.07% 73
2025
Q3
$6.46M Sell
76,942
-324
-0.4% -$26.7K 0.06% 82
2025
Q2
$6.12M Sell
77,266
-19,620
-20% -$1.56M 0.05% 88
2025
Q1
$8.7M Sell
96,886
-6,548
-6% -$611K 0.08% 76
2024
Q4
$10.3M Buy
103,434
+1,973
+2% +$203K 0.09% 67
2024
Q3
$11.5M Sell
101,461
-40
-0% -$4.75K 0.1% 63
2024
Q2
$12.6M Sell
101,501
-173
-0.2% -$22.3K 0.12% 54
2024
Q1
$13.4M Buy
101,674
+13,614
+15% +$1.68M 0.12% 53
2023
Q4
$9.6M Buy
88,060
+445
+0.5% +$46.2K 0.1% 66
2023
Q3
$9.02M Buy
87,615
+1,187
+1% +$128K 0.1% 62
2023
Q2
$9.97M Sell
86,428
-1,760
-2% -$200K 0.11% 58
2023
Q1
$9.38M Buy
88,188
+5,028
+6% +$543K 0.11% 59
2022
Q4
$9.23M Buy
83,160
+4,599
+6% +$470K 0.12% 58
2022
Q3
$6.77M Buy
78,561
+4,283
+6% +$382K 0.1% 64
2022
Q2
$6.77M Buy
74,278
+17,542
+31% +$1.56M 0.1% 56
2022
Q1
$4.66M Buy
56,736
+1,668
+3% +$132K 0.06% 73
2021
Q4
$4.22M Sell
55,068
-1,602
-3% -$128K 0.05% 77
2021
Q3
$4.26M Sell
56,670
-5,043
-8% -$384K 0.05% 76
2021
Q2
$4.8M Buy
61,713
+650
+1% +$48.3K 0.06% 70
2021
Q1
$4.49M Buy
61,063
+373
+0.6% +$27.5K 0.06% 72
2020
Q4
$4.74M Buy
60,690
+3,919
+7% +$300K 0.06% 69
2020
Q3
$4.49M Buy
56,771
+3,163
+6% +$248K 0.07% 59
2020
Q2
$3.96M Buy
53,608
+5,945
+12% +$448K 0.07% 61
2020
Q1
$3.5M Sell
47,663
-853
-2% -$67K 0.07% 56
2019
Q4
$4.21M Buy
48,516
+959
+2% +$78.8K 0.07% 66
2019
Q3
$3.82M Buy
47,557
+1,044
+2% +$83.7K 0.06% 69
2019
Q2
$3.72M Buy
46,513
+1,436
+3% +$110K 0.06% 69
2019
Q1
$3.58M Buy
45,077
+1,364
+3% +$102K 0.06% 65
2018
Q4
$3.19M Buy
43,713
+2,194
+5% +$155K 0.06% 67
2018
Q3
$2.81M Buy
41,519
+1,745
+4% +$111K 0.05% 77
2018
Q2
$2.3M Buy
39,774
+6,431
+19% +$363K 0.04% 84
2018
Q1
$1.73M Buy
33,343
+1,123
+3% +$60.7K 0.03% 101
2017
Q4
$1.73M Sell
32,220
-269
-0.8% -$14.9K 0.04% 109
2017
Q3
$1.99M Buy
32,489
+11,994
+59% +$727K 0.04% 95
2017
Q2
$1.25M Sell
20,495
-135,083
-87% -$8.22M 0.03% 113
2017
Q1
$9.43M Sell
155,578
-34,838
-18% -$2.11M 0.23% 26
2016
Q4
$10.7M Sell
190,416
-9,041
-5% -$529K 0.28% 23
2016
Q3
$11.9M Sell
199,457
-2,152
-1% -$126K 0.31% 18
2016
Q2
$11.1M Sell
201,609
-30,872
-13% -$1.64M 0.28% 18
2016
Q1
$11.7M Buy
232,481
+11,199
+5% +$548K 0.32% 25
2015
Q4
$11.2M Buy
221,282
+200,898
+986% +$10.1M 0.34% 27
2015
Q3
$961K Sell
20,384
-289
-1% -$15.4K 0.03% 77
2015
Q2
$1.12M Buy
20,673
+121
+0.6% +$6.79K 0.03% 71
2015
Q1
$1.13M Buy
20,552
+1,212
+6% +$68.6K 0.03% 73
2014
Q4
$1.05M Sell
19,340
-528
-3% -$29.4K 0.03% 77
2014
Q3
$1.12M Buy
19,868
+70
+0.4% +$3.93K 0.04% 75
2014
Q2
$1.09M Buy
19,798
+952
+5% +$51.9K 0.03% 76
2014
Q1
$1.02M Buy
18,846
+1,640
+10% +$84.9K 0.03% 76
2013
Q4
$822K Buy
17,206
+388
+2% +$17.7K 0.03% 87
2013
Q3
$764K Buy
16,818
+1,788
+12% +$81.6K 0.03% 89
2013
Q2
$666K Buy
+15,030
New +$671K 0.03% 95

Other funds holding MRK

Greenleaf Trust's MRK Position: Q2 2026 in Review

Greenleaf Trust increased its Merck (MRK) stake by 3.3% in Q2 2026, buying an estimated $306K and bringing the position to 81,295 shares worth $10.4M. The position accounts for 0.1% of the portfolio, ranked #68.

Greenleaf Trust first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.4M in Q1 2024. 1,561 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Greenleaf Trust held 81,295 shares of Merck worth $10.4M as of Q2 2026.
  • Greenleaf Trust bought 2,611 Merck shares in Q2 2026, an estimated $306K.
  • Merck made up 0.1% of Greenleaf Trust's portfolio in Q2 2026, its #68 holding.
  • Greenleaf Trust first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Greenleaf Trust's Merck position peaked at $13.4M in Q1 2024.
  • 1,561 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.